Get Your Coat!
A coating of silica could increase the thermal stability of crucial vaccines
Maryam Mahdi | | Quick Read
Researchers at the University of Bath, UK, are working on a novel vaccine that uses microscopic silica cases to protect the tuberculosis (TB) antigen and vaccine adjuvant from heat damage. Only one licensed vaccine for TB exists, but variable efficacy, particularly in areas of high disease burden, is cause for concern.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.